Dr. Reddy's Laboratories Files 6-K Report

Ticker: RDY · Form: 6-K · Filed: Jul 23, 2025 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, disclosure

TL;DR

DRL filed a 6-K, standard foreign issuer update.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 23, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, is registered with the SEC under file number 1-15182 and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing is a routine disclosure for foreign private issuers, providing an update on their reporting status to the SEC.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country, or to file with or make public in the country of its domicile or organization, or to send or give to its security holders.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is July 23, 2025.

What is the SEC file number for Dr. Reddy's Laboratories Ltd.?

The SEC file number for Dr. Reddy's Laboratories Ltd. is 1-15182.

Where is Dr. Reddy's Laboratories Ltd. headquartered?

Dr. Reddy's Laboratories Ltd. is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?

Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 23, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing